UniProt Q13153
Serine/threonine-protein kinase PAK 1 (Q13153)
Serine/threonine-protein kinase PAK 1 (UniProt Q13153), EC 2.7.11.1: 58 experimental structures on GenesisL1, 13 ligands bound, 46 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- Q13153
- Protein
- Serine/threonine-protein kinase PAK 1
- EC
- 2.7.11.1
- Experimental structures
- 58
- Predicted models
- 0
- Ligands
- 13
- Pockets
- 46 · 9 records with a druggable one
Structures
58 records of Q13153 in the MolNFT archive: 58 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1F3M | Crystal structure of human SERINE/THREONINE kinase PAK1 | x-ray diffraction | A, C, B, D | — | — |
| 1F3M | Crystal structure of human SERINE/THREONINE kinase PAK1 | x-ray diffraction | A, C, B, D | — | — |
| 1YHV | Crystal Structure of PAK1 kinase domain with two point mutations (K299R, T423E) | x-ray diffraction | A | — | — |
| 1YHV | Crystal structure of PAK1 kinase domain with two point mutations (K299R, T423E) | x-ray diffraction | A | — | — |
| 1YHW | Crystal Structure of PAK1 kinase domain with one point mutations (K299R) | x-ray diffraction | A | — | — |
| 1YHW | Crystal structure of PAK1 kinase domain with one point mutations (K299R) | x-ray diffraction | A | — | — |
| 1ZSG | beta PIX-SH3 complexed with an atypical peptide from alpha-PAK | solution nmr | B | — | — |
| 1ZSG | Beta pix-SH3 complexed with an atypical peptide from alpha-pak | solution nmr | B | — | — |
| 2HY8 | PAK1 complex with ST2001 | x-ray diffraction | 1 | — | — |
| 2HY8 | PAK1 complex with ST2001 | x-ray diffraction | 1 | — | — |
| 2QME | Crystal structure of human RAC3 in complex with CRIB domain of human p21-activated kinase 1 (PAK1) | x-ray diffraction | I | — | — |
| 2QME | Crystal structure of human RAC3 in complex with crib domain of human P21-activated kinase 1 (PAK1) | x-ray diffraction | I | — | — |
| 3DVP | Pak1 peptide bound LC8 | x-ray diffraction | C, D | — | — |
| 3DVP | PAK1 peptide bound LC8 | x-ray diffraction | C, D | — | — |
| 3FXZ | Crystal structure of PAK1 kinase domain with ruthenium complex lambda-FL172 | x-ray diffraction | A | — | — |
| 3FXZ | Crystal structure of PAK1 kinase domain with ruthenium complex lambda- FL172 | x-ray diffraction | A | — | — |
| 3FY0 | Crystal structure of PAK1 kinase domain with ruthenium complex DW1 | x-ray diffraction | A | — | — |
| 3FY0 | Crystal structure of PAK1 kinase domain with ruthenium complex DW1 | x-ray diffraction | A | — | — |
| 3Q4Z | Structure of unphosphorylated PAK1 kinase domain | x-ray diffraction | A, B | — | — |
| 3Q4Z | Structure of unphosphorylated PAK1 kinase domain | x-ray diffraction | A, B | — | — |
| 3Q52 | Structure of phosphorylated PAK1 kinase domain | x-ray diffraction | A | — | — |
| 3Q52 | Structure of phosphorylated PAK1 kinase domain | x-ray diffraction | A | — | — |
| 3Q53 | Structure of phosphorylated PAK1 kinase domain in complex with ATP | x-ray diffraction | A | — | — |
| 3Q53 | Structure of phosphorylated PAK1 kinase domain in complex with ATP | x-ray diffraction | A | — | — |
| 4DAW | Crystal structure of PAK1 kinase domain with the ruthenium phthalimide complex | x-ray diffraction | A | — | — |
| 4DAW | Crystal structure of PAK1 kinase domain with the ruthenium phthalimide complex | x-ray diffraction | A | — | — |
| 4EQC | Crystal structure of PAK1 kinase domain in complex with FRAX597 inhibitor | x-ray diffraction | A | — | — |
| 4EQC | Crystal structure of PAK1 kinase domain in complex with FRAX597 inhibitor | x-ray diffraction | A | — | — |
| 4O0R | Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors | x-ray diffraction | A, B | — | — |
| 4O0R | Back pocket flexibility provides group-II pak selectivity for type 1 kinase inhibitors | x-ray diffraction | A, B | — | — |
| 4O0T | Back pocket flexibility provides group-II PAK selectivity for type 1 kinase inhibitors | x-ray diffraction | A, B | — | — |
| 4O0T | Back pocket flexibility provides group-II pak selectivity for type 1 kinase inhibitors | x-ray diffraction | A, B | — | — |
| 4P90 | Crystal structure of the kinase domain of human PAK1 in complex with compound 15 | x-ray diffraction | A, B | — | — |
| 4P90 | Crystal structure of the kinase domain of human PAK1 in complex with compound 15 | x-ray diffraction | A, B | — | — |
| 4ZJI | PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine | x-ray diffraction | A, B, C, D | 4OQ, MG | 11 (best 0.80) |
| 4ZJI | PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin- 1-yl)-dibenzodiazepine | x-ray diffraction | A, B, C, D | — | — |
| 4ZJJ | PAK1 in complex with (S)-N-(tert-butyl)-3-((2-chloro-5-ethyl-8-fluoro-dibenzodiazepin-11-yl)amino)py… | x-ray diffraction | A, B, C, D | 4OR, MG | 11 (best 0.78) |
| 4ZJJ | PAK1 in complex with (S)-N-(tert-butyl)-3-((2-chloro-5-ethyl-8-fluoro… | x-ray diffraction | A, B, C, D | — | — |
| 4ZLO | Serine/threonine-protein kinase PAK1 complexed with a dibenzodiazepine: identification of an… | x-ray diffraction | A, B | 4PV | 4 (best 0.68) |
| 4ZLO | SERINE/THREONINE-protein kinase PAK1 complexed with a dibenzodiazepine: identification of an… | x-ray diffraction | A, B | — | — |
| 4ZY4 | Crystal structure of P21 activated kinase 1 in complex with an inhibitor compound 4 | x-ray diffraction | A, B | 4T3, SO4 | 4 (best 0.78) |
| 4ZY4 | Crystal structure of P21 activated kinase 1 in complex with an inhibitor compound 4 | x-ray diffraction | A, B | — | — |
| 4ZY5 | Crystal structure of P21-activated kinase 1 in complex with an inhibitor compound 17 | x-ray diffraction | A, B | — | — |
| 4ZY6 | Crystal structure of P21-activated kinase 1 in complex with an inhibitor compound 29 | x-ray diffraction | A, B | 4T6, SO4 | 4 (best 0.73) |
| 4ZY6 | Crystal structure of P21-activated kinase 1 in complex with an inhibitor compound 29 | x-ray diffraction | A, B | — | — |
| 5DEW | Crystal structure of PAK1 in complex with an inhibitor compound 5 | x-ray diffraction | A, B | — | — |
| 5DEY | Crystal structure of PAK1 in complex with an inhibitor compound G-5555 | x-ray diffraction | A, B | — | — |
| 5DFP | Crystal structure of PAK1 in complex with an inhibitor compound FRAX1036 | x-ray diffraction | A | 59U | 2 (best 0.68) |
| 5DFP | Crystal structure of PAK1 in complex with an inhibitor compound FRAX1036 | x-ray diffraction | A | — | — |
| 5IME | Crystal structure of P21-activated kinase 1 (PAK1) in complex with compound 9 | x-ray diffraction | A, B | 6BZ | — |
| 5IME | Crystal structure of P21-activated kinase 1 (PAK1) in complex with compound 9 | x-ray diffraction | A, B | — | — |
| 5KBQ | Pak1 in complex with bis-anilino pyrimidine inhibitor | x-ray diffraction | A, B | IPV | 5 (best 0.67) |
| 5KBQ | PAK1 in complex with bis-anilino pyrimidine inhibitor | x-ray diffraction | A, B | IPV | — |
| 5KBR | PAK1 in complex with 7-azaindole inhibitor | x-ray diffraction | A, B | IPW | — |
| 6B16 | P21-activated kinase 1 in complex with a 4-azaindole inhibitor | x-ray diffraction | A, B | C7Y, SO4 | — |
| 7VTO | The crystal structure of PAK1 with the inhibitor GW8510 | x-ray diffraction | A, B | 107 | 3 (best 0.80) |
| 8X5Z | The Crystal Structure of PAK1 kinase domain from Biortus. | x-ray diffraction | A | — | 2 (best 0.58) |
| Q13153 | AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase pak 1 (Q13153) | — | — | — |
Ligands
- SO4 · Sulfate ion · in 3 records
- IPV · [4-methyl-3-[methyl-[2-[(3-methylsulfonyl-5-morpholin-4-yl-phenyl)amino]pyrimidin-4-yl]amino]phenyl]methanol · in 2 records
- MG · Magnesium ion · in 2 records
- 107 · 4-[(7-oxo-7H-thiazolo[5,4-e]indol-8-ylmethyl)-amino]-N-pyridin-2-yl-benzenesulfonamide · in 1 record
- 4OQ · 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine · in 1 record
- 4OR · (S)-N-(tert-butyl)-3-((2-chloro-5-ethyl-8-fluoro-dibenzodiazepin-11-yl)amino)pyrrolidine-1-carboxamide · in 1 record
- 4PV · 2,8-difluoro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine · in 1 record
- 4T3 · 2-(4-aminopiperidin-1-yl)-N-(5-cyclopropyl-1H-pyrazol-3-yl)thieno[3,2-d]pyrimidin-4-amine · in 1 record
- 4T6 · N~2~-[(7-chloro-1H-benzimidazol-6-yl)methyl]-N~4~-(5-cyclopropyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine · in 1 record
- 59U · 6-[2-chloro-4-(6-methylpyrazin-2-yl)phenyl]-8-ethyl-2-{[2-(1-methylpiperidin-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one · in 1 record
- 6BZ · 8-(3-aminopropyl)-6-[2-chloro-4-(3-methyl-2-oxopyrazin-1(2H)-yl)phenyl]-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one · in 1 record
- C7Y · N~4~-(5-cyclopropyl-1H-pyrazol-3-yl)-N~2~-[(1S)-1-(1H-pyrrolo[3,2-b]pyridin-5-yl)ethyl]pyrimidine-2,4-diamine · in 1 record
- IPW · (4-chlorophenyl)-[5-(1-piperidin-4-ylpyrazol-4-yl)-1~{H}-pyrrolo[2,3-b]pyridin-3-yl]methanone · in 1 record
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.